In vivo, reconstitution of HAPLN1 in aged mice increased the number of LN metastases, but reduced visceral metastases (18). Similarly, androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma (19). Here, HAPLN1 is linked to renal cell carcinoma.